Meanwhile, CCL21/CCL19 attract CCR7 + T cells as well as other immune cells and alter the ectopic lymph node structure associated with cancer prognosis by co-localizing synaptic cells and T cells, thereby promoting immune activity in the tumor microenvironment (TME) leading to immune infiltration [48]. This evidence concerns the gene CCL19 and cancer.